Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H16N2O3 |
| Molecular Weight | 248.2777 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C(CN)C1=CNC2=C1C=C(OC)C=C2
InChI
InChIKey=YFEDJMLMWJSRJJ-UHFFFAOYSA-N
InChI=1S/C13H16N2O3/c1-17-8-3-4-12-9(5-8)11(7-15-12)10(6-14)13(16)18-2/h3-5,7,10,15H,6,14H2,1-2H3
| Molecular Formula | C13H16N2O3 |
| Molecular Weight | 248.2777 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Indorenate (TR3369, INDO) is a serotonin-like compound with high affinity for 5- HT1A receptors and a lower affinity for 5-HT1C and 5-HT1B receptors. Indorenate possesses antihypertensive and anxiolytic activity in animal behaviour tests. Similar to other serotonin receptor agonists, Indorenate also has anorectic activity; this effect was blocked by the administration of the 5-HT2A/2C receptor antagonists cinanserin, cyproheptadine, metergoline and methysergide. A unpublished clinical trial confirmed its antihypertensive activity in men.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15993434
rats: 1, 3, 10 mg/kg, i.p.
Route of Administration:
Intraperitoneal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:41:10 GMT 2025
by
admin
on
Wed Apr 02 09:41:10 GMT 2025
|
| Record UNII |
AV9L041QA4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47794
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C033600
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
73758-06-2
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
INDORENATE
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
AV9L041QA4
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
4929
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
DTXSID2048400
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
C83802
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
71987
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
SUB08185MIG
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
100000083396
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL414636
Created by
admin on Wed Apr 02 09:41:10 GMT 2025 , Edited by admin on Wed Apr 02 09:41:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |